The Novacyt Group of companies includes Primer Design, Yourgene Health and MyGo (IT-IS International) – creating a stronger, global diagnostics business.
The companies work together to develop new innovative diagnostic solutions to improve healthcare outcomes and drive the growth of the business.
The Group broadens the scale and depth of our expertise to build long term value for our customers.
Learn about the 3 brands below:
With over 20 years experience in designing, validating and manufacturing assays, Primerdesign provide real-time assays from research to surveillance.
Primerdesign’s mission is to enable their customers to improve health outcomes, ensuring Food Safety & Integrity of Supply Chain and enhance the well-being of pets, animals and livestock by providing an extensive portfolio of qPCR products and delivering custom development services and solutions.
Primerdesign empowers diagnostic laboratories, genetic testing hubs and outbreak surveillance programmes to rapidly detect, monitor and respond to pathogens and genetic targets with confidence.
Their ready-to-deploy, open-platform qPCR assays and integrated sample-to-result workflows deliver high-performance molecular detection across the industry’s broadest pathogen menu.
From customisable assays to OEM-ready, end-to-end qPCR kits, Primerdesign enable faster insights, scalable surveillance and accelerated outbreak response.
Yourgene Health offers a comprehensive suite of non-invasive prenatal testing (NIPT) solutions, including a complete NGS workflow designed to provide laboratories with flexible, scalable testing and a broad clinical menu, tailored to their needs. In addition, Yourgene also offer a NIPT sample service for healthcare professionals.
Supporting the wider reproductive lifecycle, Yourgene offer a portfolio of PCR-based clinical screening assays, including tests for cystic fibrosis, aneuploidy analysis, pregnancy loss, male factor infertility, and thrombosis risk.
As part of the expanding Precision Medicine portfolio, the Yourgene® DPYD genotyping PCR assay supports safer chemotherapy regimes, by identifying patients at risk of severe fluoropyrimidine toxicity.
Powered by Ranger® Technology, Yourgene’s portfolio of automated DNA size selection instruments delivers high-precision fragment selection and dynamic target enrichment across a wide range of clinical and research sequencing applications. Designed to support laboratories from low- to high-throughput workflows, Ranger® instruments provide an innovative solution for applications including NIPT, gene synthesis, CRISPR gene editing, and long-read sequencing.
Southern Cross Diagnostics (SCD) are a locally-owned Australian distributor specialising in the sales and support of human diagnostics and life science products to the Australian clinical and scientific community.
They are committed to supplying customers with quality human diagnostics and life science products that meet and exceed their expectations. Southern Cross are committed to ongoing improvement and compliance of their business operations and sustainable practices within the framework of social and environmental responsibility. SCD are committed to building trust and authentic relationships with suppliers and all stakeholders to ensure consistent delivery of high quality, safe and effective solutions to enhance customer satisfaction.
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
For Careers information for the Novacyt Group, please click the link button below to view our vacancies.
